BioSkryb

OverviewSuggest Edit

Bioskryb is a company bringing solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system. Its technology enables coverage of the entire genome during DNA amplification and allows for accuracy and uniformity in DNA sequence coverage and base calling – the identification of the individual DNA bases.

TypePrivate
Founded2018
HQDurham, NC, US
Websitebioskryb.com

Latest Updates

Employees (est.) (Mar 2021)23(+15%)
Cybersecurity ratingAMore

Key People/Management at BioSkryb

Jay West

Jay West

CEO / Co-Founder and Board Member
Charles Gawad

Charles Gawad

Director / Co-Founder
Wendi Carter

Wendi Carter

VP of Accounting and Finance
Debrah Herman

Debrah Herman

CFO
Anne Vrolyk

Anne Vrolyk

VP of Business Development
David Michael

David Michael

Managing Partner
Show more

BioSkryb Office Locations

BioSkryb has an office in Durham
Durham, NC, US (HQ)
701 W Main St #200
Show all (1)

BioSkryb Financials and Metrics

Summary Metrics

Founding Date

2018

BioSkryb total Funding

$11.5 m

BioSkryb latest funding size

$11.50 m

Time since last funding

a year ago

BioSkryb investors

BioSkryb's latest funding round in January 2020 was reported to be $11.5 m. In total, BioSkryb has raised $11.5 m
Show all financial metrics

BioSkryb Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

BioSkryb Online and Social Media Presence

Embed Graph

BioSkryb News and Updates

BioSkryb Launches Researcher Early Access Program for Genomic Amplification Technology

DURHAM, N.C., Aug. 3, 2020 /PRNewswire/ -- BioSkryb, Inc. ("BioSkryb"), a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has launched an Early Access Program (EAP) for researchers to test its...

BioSkryb Blogs

BioSkryb Announces the Winners of Its Grant Program to Aid Research Using Primary Template-directed Amplification Technology

DURHAM, N.C.--(BUSINESS WIRE)--Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was crea…

BioSkryb Announces Research Grants to Access Breakthrough Single-Cell Whole Genome Amplification Technologies

DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb, Inc., a developer of genomic amplification technologies, today announced the launch of a research grant program sponsored by the company to accelerate innovation of single-cell genomic studies using its primary template-directed amplification (PTA) technology…

BioSkryb Announces First Data Demonstrating Novel PTA Technology Improves Accuracy in Whole Genome Amplification for Single Cell Analyses

December 01, 2020 08:00 AM EST DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb, Inc., a developer of genomic amplification technologies, today reported the release of foundational data before publication on the preprint server, bioRxiv, demonstrating the superior ability of primary template-directed amplifi…

BioSkryb’s Novel PTA Technology for High-Quality Single-Cell Whole Genome Amplification Will Be Commercially Available for the First Time at ASHG 2020

Research being presented at ASHG 2020 to support use of PTA technology in the study of genetic variants that contribute to drug resistance in cancer treatment October 26, 2020 09:00 AM Eastern Daylight Time DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb, Inc., a developer of genomic amplification technolog…

BioSkryb Frequently Asked Questions

  • When was BioSkryb founded?

    BioSkryb was founded in 2018.

  • Who are BioSkryb key executives?

    BioSkryb's key executives are Jay West, Charles Gawad and Wendi Carter.

  • How many employees does BioSkryb have?

    BioSkryb has 23 employees.

  • Who are BioSkryb competitors?

    Competitors of BioSkryb include BioIVT, Abcam and Galera Therapeutics.

  • Where is BioSkryb headquarters?

    BioSkryb headquarters is located at 701 W Main St #200, Durham.

  • Where are BioSkryb offices?

    BioSkryb has an office in Durham.

  • How many offices does BioSkryb have?

    BioSkryb has 1 office.